nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—Platinum-containing Compounds—Carboplatin—ocular cancer	0.624	1	CiPCiCtD
Oxaliplatin—ATP7A—Carboplatin—ocular cancer	0.0442	0.122	CbGbCtD
Oxaliplatin—ATP7B—Carboplatin—ocular cancer	0.0442	0.122	CbGbCtD
Oxaliplatin—MT1A—Carboplatin—ocular cancer	0.0442	0.122	CbGbCtD
Oxaliplatin—MT2A—Carboplatin—ocular cancer	0.0442	0.122	CbGbCtD
Oxaliplatin—SLC31A1—Carboplatin—ocular cancer	0.0351	0.0968	CbGbCtD
Oxaliplatin—SOD1—Carboplatin—ocular cancer	0.0351	0.0968	CbGbCtD
Oxaliplatin—GSTT1—Carboplatin—ocular cancer	0.0294	0.081	CbGbCtD
Oxaliplatin—GSTM1—Carboplatin—ocular cancer	0.0254	0.07	CbGbCtD
Oxaliplatin—NQO1—Carboplatin—ocular cancer	0.0202	0.0556	CbGbCtD
Oxaliplatin—GSTP1—Carboplatin—ocular cancer	0.0183	0.0506	CbGbCtD
Oxaliplatin—MPO—Carboplatin—ocular cancer	0.0105	0.0291	CbGbCtD
Oxaliplatin—ABCG2—Dactinomycin—ocular cancer	0.00495	0.0137	CbGbCtD
Oxaliplatin—ABCC2—Carboplatin—ocular cancer	0.00368	0.0102	CbGbCtD
Oxaliplatin—ABCG2—Carboplatin—ocular cancer	0.00333	0.00918	CbGbCtD
Oxaliplatin—MT2A—Copper homeostasis—CCND1—ocular cancer	0.000122	0.00933	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00012	0.00918	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDKN2C—ocular cancer	0.000115	0.00876	CbGpPWpGaD
Oxaliplatin—MT1A—Copper homeostasis—AKT1—ocular cancer	0.000112	0.00856	CbGpPWpGaD
Oxaliplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00011	0.00839	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—H1F0—ocular cancer	0.000108	0.00824	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—E2F2—ocular cancer	0.000105	0.00803	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—CDKN1B—ocular cancer	0.000101	0.00771	CbGpPWpGaD
Oxaliplatin—ATP7B—Copper homeostasis—TP53—ocular cancer	0.000101	0.00768	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	9.88e-05	0.00754	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—CCND1—ocular cancer	9.63e-05	0.00735	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDK6—ocular cancer	9.51e-05	0.00726	CbGpPWpGaD
Oxaliplatin—SOD1—FOXA1 transcription factor network—CDKN1B—ocular cancer	9.37e-05	0.00715	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—E2F2—ocular cancer	9.18e-05	0.007	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—RBBP4—ocular cancer	9.12e-05	0.00696	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—E2F3—ocular cancer	9.12e-05	0.00696	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—MDM2—ocular cancer	8.98e-05	0.00686	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—EP300—ocular cancer	8.87e-05	0.00677	CbGpPWpGaD
Oxaliplatin—ATP7A—Copper homeostasis—TP53—ocular cancer	8.56e-05	0.00653	CbGpPWpGaD
Oxaliplatin—ATP7B—Copper homeostasis—AKT1—ocular cancer	8.5e-05	0.00649	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TFDP1—ocular cancer	8.48e-05	0.00647	CbGpPWpGaD
Oxaliplatin—SOD1—FOXA1 transcription factor network—EP300—ocular cancer	8.23e-05	0.00628	CbGpPWpGaD
Oxaliplatin—SLC31A1—Copper homeostasis—TP53—ocular cancer	8.21e-05	0.00626	CbGpPWpGaD
Oxaliplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	8.19e-05	0.00625	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—TP53—ocular cancer	8.05e-05	0.00614	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—RBBP4—ocular cancer	7.96e-05	0.00607	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—E2F3—ocular cancer	7.96e-05	0.00607	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—CCND1—ocular cancer	7.82e-05	0.00597	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—MYC—ocular cancer	7.73e-05	0.0059	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TGFB1—ocular cancer	7.71e-05	0.00588	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	7.69e-05	0.00587	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	7.69e-05	0.00587	CbGpPWpGaD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—MDM2—ocular cancer	7.41e-05	0.00566	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TFDP1—ocular cancer	7.4e-05	0.00565	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDKN2B—ocular cancer	7.33e-05	0.0056	CbGpPWpGaD
Oxaliplatin—ATP7A—Copper homeostasis—AKT1—ocular cancer	7.23e-05	0.00552	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PSPH—ocular cancer	7.16e-05	0.00547	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	7.1e-05	0.00542	CbGpPWpGaD
Oxaliplatin—SLC31A1—Copper homeostasis—AKT1—ocular cancer	6.93e-05	0.00529	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1B—ocular cancer	6.87e-05	0.00524	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—AKT1—ocular cancer	6.8e-05	0.00519	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—GNA11—ocular cancer	6.77e-05	0.00517	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	6.75e-05	0.00516	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	6.75e-05	0.00516	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—E2F1—ocular cancer	6.73e-05	0.00514	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	6.7e-05	0.00511	CbGpPWpGaD
Oxaliplatin—SOD1—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	6.63e-05	0.00506	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—ocular cancer	6.62e-05	0.00506	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TP53—ocular cancer	6.35e-05	0.00484	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—ocular cancer	6.34e-05	0.00484	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	6.3e-05	0.00481	CbGpPWpGaD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN1A—ocular cancer	6.24e-05	0.00477	CbGpPWpGaD
Oxaliplatin—SOD1—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	6.1e-05	0.00466	CbGpPWpGaD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—ocular cancer	5.94e-05	0.00453	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	5.89e-05	0.00449	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	5.87e-05	0.00448	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDK2—ocular cancer	5.8e-05	0.00443	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	5.78e-05	0.00441	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CDKN1B—ocular cancer	5.73e-05	0.00438	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDK6—ocular cancer	5.73e-05	0.00437	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDK4—ocular cancer	5.49e-05	0.00419	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CCND1—ocular cancer	5.47e-05	0.00418	CbGpPWpGaD
Oxaliplatin—SOD1—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	5.32e-05	0.00406	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CDKN1A—ocular cancer	5.29e-05	0.00404	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—TP53—ocular cancer	5.15e-05	0.00393	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—EP300—ocular cancer	5.04e-05	0.00384	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDK6—ocular cancer	5e-05	0.00381	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CDKN1B—ocular cancer	4.88e-05	0.00372	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—RB1—ocular cancer	4.77e-05	0.00364	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	4.75e-05	0.00362	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CCND1—ocular cancer	4.65e-05	0.00355	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	4.62e-05	0.00353	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PSPH—ocular cancer	4.62e-05	0.00352	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CDKN1A—ocular cancer	4.5e-05	0.00343	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet degranulation—TGFB1—ocular cancer	4.44e-05	0.00339	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDKN2B—ocular cancer	4.41e-05	0.00337	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—MYC—ocular cancer	4.39e-05	0.00335	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—AKT1—ocular cancer	4.35e-05	0.00332	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—EP300—ocular cancer	4.28e-05	0.00327	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TP53—ocular cancer	4.26e-05	0.00325	CbGpPWpGaD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	4.23e-05	0.00323	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	4.12e-05	0.00315	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PSPH—ocular cancer	4.09e-05	0.00312	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—MDM2—ocular cancer	4.07e-05	0.0031	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—E2F1—ocular cancer	4.05e-05	0.00309	CbGpPWpGaD
Oxaliplatin—CYP1B1—Tryptophan metabolism—MDM2—ocular cancer	4.05e-05	0.00309	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PSPH—ocular cancer	3.93e-05	0.003	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDKN2B—ocular cancer	3.85e-05	0.00294	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PSPH—ocular cancer	3.83e-05	0.00292	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	3.76e-05	0.00287	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—MYC—ocular cancer	3.73e-05	0.00285	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TP53—ocular cancer	3.72e-05	0.00284	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDKN1B—ocular cancer	3.71e-05	0.00283	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	3.7e-05	0.00282	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	3.7e-05	0.00282	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—ocular cancer	3.64e-05	0.00278	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—AKT1—ocular cancer	3.6e-05	0.00274	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	3.56e-05	0.00272	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—E2F1—ocular cancer	3.54e-05	0.0027	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDK2—ocular cancer	3.49e-05	0.00267	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—GNA11—ocular cancer	3.49e-05	0.00267	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—HRAS—ocular cancer	3.45e-05	0.00263	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDKN1A—ocular cancer	3.43e-05	0.00262	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	3.41e-05	0.0026	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDK4—ocular cancer	3.3e-05	0.00252	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—EP300—ocular cancer	3.26e-05	0.00249	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—GNAQ—ocular cancer	3.25e-05	0.00248	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	3.25e-05	0.00248	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	3.25e-05	0.00248	CbGpPWpGaD
Oxaliplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	3.2e-05	0.00244	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDK2—ocular cancer	3.05e-05	0.00233	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—HRAS—ocular cancer	2.93e-05	0.00224	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—HDAC1—ocular cancer	2.93e-05	0.00223	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	2.92e-05	0.00223	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDK4—ocular cancer	2.88e-05	0.0022	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—RB1—ocular cancer	2.87e-05	0.00219	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	2.83e-05	0.00216	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	2.82e-05	0.00215	CbGpPWpGaD
Oxaliplatin—GSTM1—NRF2 pathway—TGFB1—ocular cancer	2.81e-05	0.00215	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	2.76e-05	0.0021	CbGpPWpGaD
Oxaliplatin—CYP2E1—Tryptophan metabolism—MDM2—ocular cancer	2.64e-05	0.00202	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PSPH—ocular cancer	2.64e-05	0.00201	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	2.63e-05	0.00201	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—RB1—ocular cancer	2.51e-05	0.00191	CbGpPWpGaD
Oxaliplatin—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	2.49e-05	0.0019	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—MDM2—ocular cancer	2.45e-05	0.00187	CbGpPWpGaD
Oxaliplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	2.45e-05	0.00187	CbGpPWpGaD
Oxaliplatin—GSTP1—NRF2 pathway—TGFB1—ocular cancer	2.39e-05	0.00183	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—ocular cancer	2.33e-05	0.00178	CbGpPWpGaD
Oxaliplatin—NQO1—NRF2 pathway—TGFB1—ocular cancer	2.33e-05	0.00178	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	2.28e-05	0.00174	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	2.28e-05	0.00174	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	2.27e-05	0.00173	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—GNA11—ocular cancer	2.25e-05	0.00172	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDKN1B—ocular cancer	2.24e-05	0.00171	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	2.22e-05	0.0017	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	2.21e-05	0.00169	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—MDM2—ocular cancer	2.14e-05	0.00163	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	2.1e-05	0.0016	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—GNAQ—ocular cancer	2.1e-05	0.0016	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—CDK2—ocular cancer	2.08e-05	0.00158	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDKN1A—ocular cancer	2.06e-05	0.00157	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HRAS—ocular cancer	2e-05	0.00153	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	2e-05	0.00153	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	2e-05	0.00153	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	1.97e-05	0.0015	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—EP300—ocular cancer	1.96e-05	0.0015	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDKN1B—ocular cancer	1.95e-05	0.00149	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	1.86e-05	0.00142	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PSPH—ocular cancer	1.84e-05	0.0014	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDKN1A—ocular cancer	1.8e-05	0.00137	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	1.74e-05	0.00133	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	1.74e-05	0.00133	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—EP300—ocular cancer	1.71e-05	0.00131	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PSPH—ocular cancer	1.67e-05	0.00128	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PSPH—ocular cancer	1.65e-05	0.00126	CbGpPWpGaD
Oxaliplatin—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	1.59e-05	0.00121	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PSPH—ocular cancer	1.54e-05	0.00118	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—GNA11—ocular cancer	1.45e-05	0.00111	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	1.45e-05	0.00111	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	1.45e-05	0.00111	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—ocular cancer	1.4e-05	0.00107	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	1.37e-05	0.00104	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—AKT1—ocular cancer	1.37e-05	0.00104	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—GNAQ—ocular cancer	1.35e-05	0.00103	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	1.34e-05	0.00102	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.34e-05	0.00102	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—GNA11—ocular cancer	1.29e-05	0.000983	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	1.27e-05	0.000973	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	1.27e-05	0.000973	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—GNA11—ocular cancer	1.24e-05	0.000943	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—ocular cancer	1.23e-05	0.000936	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—GNA11—ocular cancer	1.2e-05	0.000919	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PSPH—ocular cancer	1.2e-05	0.000916	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—GNAQ—ocular cancer	1.2e-05	0.000914	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—MDM2—ocular cancer	1.19e-05	0.000909	CbGpPWpGaD
Oxaliplatin—ABCC2—NRF2 pathway—TGFB1—ocular cancer	1.17e-05	0.000894	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—EP300—ocular cancer	1.17e-05	0.00089	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—GNAQ—ocular cancer	1.15e-05	0.000877	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PSPH—ocular cancer	1.13e-05	0.000864	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	1.12e-05	0.000858	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—GNAQ—ocular cancer	1.12e-05	0.000854	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	1.11e-05	0.000848	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	1.11e-05	0.000845	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CDKN1B—ocular cancer	1.09e-05	0.00083	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	1.05e-05	0.0008	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TGFB1—ocular cancer	1.01e-05	0.000774	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CDKN1A—ocular cancer	1e-05	0.000766	CbGpPWpGaD
Oxaliplatin—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	9.95e-06	0.000759	CbGpPWpGaD
Oxaliplatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	9.74e-06	0.000743	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—EP300—ocular cancer	9.55e-06	0.000729	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	8.72e-06	0.000666	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—MDM2—ocular cancer	8.62e-06	0.000658	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—ocular cancer	8.35e-06	0.000637	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—GNA11—ocular cancer	8.3e-06	0.000634	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—MDM2—ocular cancer	8.03e-06	0.000613	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—HRAS—ocular cancer	7.98e-06	0.000609	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—GNAQ—ocular cancer	7.72e-06	0.000589	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—EP300—ocular cancer	7.53e-06	0.000575	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PSPH—ocular cancer	7.22e-06	0.000551	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—AKT1—ocular cancer	7.05e-06	0.000538	CbGpPWpGaD
Oxaliplatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	6.71e-06	0.000512	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HRAS—ocular cancer	6.54e-06	0.000499	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	6.17e-06	0.000471	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—GNA11—ocular cancer	5.78e-06	0.000441	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—AKT1—ocular cancer	5.77e-06	0.000441	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	5.75e-06	0.000439	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—GNAQ—ocular cancer	5.38e-06	0.00041	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—GNA11—ocular cancer	5.26e-06	0.000402	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—GNA11—ocular cancer	5.21e-06	0.000397	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—GNAQ—ocular cancer	4.89e-06	0.000373	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—EP300—ocular cancer	4.85e-06	0.00037	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—GNA11—ocular cancer	4.85e-06	0.00037	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—GNAQ—ocular cancer	4.84e-06	0.00037	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—HRAS—ocular cancer	4.73e-06	0.000361	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—AKT1—ocular cancer	4.55e-06	0.000347	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—GNAQ—ocular cancer	4.51e-06	0.000344	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—HRAS—ocular cancer	4.41e-06	0.000336	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.34e-06	0.000331	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—EP300—ocular cancer	4.3e-06	0.000329	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—EP300—ocular cancer	4.13e-06	0.000315	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—EP300—ocular cancer	4.02e-06	0.000307	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—GNA11—ocular cancer	3.78e-06	0.000288	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—GNA11—ocular cancer	3.56e-06	0.000272	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—GNAQ—ocular cancer	3.51e-06	0.000268	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—GNAQ—ocular cancer	3.31e-06	0.000253	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—AKT1—ocular cancer	2.93e-06	0.000224	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—EP300—ocular cancer	2.77e-06	0.000212	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.67e-06	0.000204	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—AKT1—ocular cancer	2.6e-06	0.000199	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—AKT1—ocular cancer	2.49e-06	0.00019	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—AKT1—ocular cancer	2.43e-06	0.000186	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—GNA11—ocular cancer	2.27e-06	0.000173	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—GNAQ—ocular cancer	2.11e-06	0.000161	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—EP300—ocular cancer	1.93e-06	0.000147	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—EP300—ocular cancer	1.76e-06	0.000134	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—EP300—ocular cancer	1.74e-06	0.000133	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.7e-06	0.00013	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—AKT1—ocular cancer	1.68e-06	0.000128	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—EP300—ocular cancer	1.62e-06	0.000124	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—EP300—ocular cancer	1.26e-06	9.63e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—EP300—ocular cancer	1.19e-06	9.08e-05	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—AKT1—ocular cancer	1.17e-06	8.91e-05	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—AKT1—ocular cancer	1.06e-06	8.11e-05	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—AKT1—ocular cancer	1.05e-06	8.02e-05	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—AKT1—ocular cancer	9.8e-07	7.48e-05	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—AKT1—ocular cancer	7.63e-07	5.82e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—EP300—ocular cancer	7.59e-07	5.79e-05	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—AKT1—ocular cancer	7.19e-07	5.49e-05	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—AKT1—ocular cancer	4.59e-07	3.5e-05	CbGpPWpGaD
